Alexandra MacLean - Jun 29, 2023 Form 4 Insider Report for AVENUE THERAPEUTICS, INC. (ATXI)

Role
Chief Executive Officer, Director
Signature
/s/ David Jin, attorney-in-fact
Stock symbol
ATXI
Transactions as of
Jun 29, 2023
Transactions value $
$0
Form type
4
Date filed
7/3/2023, 01:05 PM
Previous filing
Aug 3, 2022
Next filing
Sep 25, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXI Employee stock option (right to buy) Award $0 +800K $0.00 800K Jun 29, 2023 Common Stock 800K $1.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in accordance with the following schedule: (i) 25% of the shares subject to the option vest on August 1, 2023; (ii) 25% of the shares subject to the option vest on August 1, 2024; (iii) 25% of the shares subject to the option vest on August 1, 2025; and (iv) 25% of the shares subject to the option vest on August 1, 2026.